Alliance Foundation Trials, LLC (AFT) is a pioneering research organization dedicated to reducing the impact of cancer. Established in 2014, AFT specializes in the development and execution of cancer clinical trials. Collaborating closely with pharmaceutical partners, research collaborators, and the Alliance for Clinical Trials in Oncology scientific investigators and institutional member network, AFT is committed to realizing the vision of the Alliance for Clinical Trials in Oncology. This vision revolves around uniting a diverse community of scientists and clinicians from various disciplines with the shared goal of discovering, validating, and disseminating effective strategies for both the prevention and treatment of cancer.
AFT operates within the biotechnology and healthcare industries, demonstrating its focus on innovative solutions within these critical sectors. While specific investment details and headquarters information are not currently available, AFT's dedication to impactful research in the fight against cancer is evident. The organization's drive to collaborate with a broad network of industry professionals and researchers showcases its commitment to driving meaningful change in the battle against cancer.
There is no investment information
No recent news or press coverage available for Alliance Foundation Trials, LLC.